Given the rapid proliferation of AI-equipped medical devices across U.S. healthcare, unintended effects should surprise no one. 

FDA commissioner Robert Califf recently suggested the agency may need to double its workforce. And that’s just to oversee AI. 

See What’s New:

The FDA’s fledgling Digital Health Advisory Committee (DHAC) only held its first meeting last week, but it has already committed its thinking to writing. 

An influential industry group, AdvaMed, really likes President-Elect Trump’s choice of Dr. Oz for CMS administrator. 

It’s been years since AI proponents started promising big returns on healthcare providers’ investments in the technology. The results have yet to catch up with the pitches. What’s the holdup? 

Medtronic has launched new research into AI's potential to identify patients with severe aortic stenosis and other worrying symptoms. The company hopes to overcome longstanding health disparities and reach individuals who may otherwise go untreated.

Black-box outputs aren’t just a problem with AI. They’re also a problem with physicians. 

The pace of AI adoption is quickening in the sector, which includes biopharmaceuticals, digital health, clinical diagnostics and medical devices.

Working with Medicare Advantage insurance plans is like playing poker in the Wild West. And it’s gotten a lot harder to win since the cowboys started using AI.